Cipla USA Inc.
Warren, NJ
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 10 Independence Blvd #400, Warren, NJ 07059, USA
- Website
- cipla.com
- Founded
- 1935
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi - Aventis U S LLC | Morristown, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Cipla USA Inc. is a leading global pharmaceutical company with a portfolio of over 1,500 products across various therapeutic categories. It is a foreign-owned, for-profit corporate entity registered to receive federal awards from the U.S. government. Cipla utilizes cutting-edge technology to develop affordable and innovative medicines aimed at providing access to quality healthcare.
Cipla USA Inc. holds multiple federal contract IDVs for the delivery of pharmaceutical products to government agencies. Notable IDVs include an indefinite delivery contract for $9.5 million awarded by the Department of Veterans Affairs (VA) National Acquisition Center to supply ambrisentan tablets through March 2025. This specialty drug requires enrollment in a shared risk mitigation program, and Cipla must sponsor government pharmacies as authorized outpatient distributors. Additionally, Cipla has been awarded $225,000 in multiple awards under GSA's Pharmaceuticals and Drugs Schedule to deliver a range of medications and hematology products to VA medical facilities through February 2026. These pre-competed schedule IDVs streamline procurement processes for routine pharmaceutical needs across the VA's integrated service networks. Cipla also held an interim $25,000 agreement under this same GSA schedule with the VA's Veterans Integrated Service Network 12 in 2020.
Quick answers
Is Cipla USA Inc. registered in SAM.gov?
Yes. Cipla USA Inc.'s SAM.gov registration is active through October 12, 2027.
What is Cipla USA Inc.'s CAGE code?
Cipla USA Inc.'s CAGE code is 7WV84, and its Unique Entity ID (UEI) is Q2MKMCP1CDT7.
Which contract vehicles does Cipla USA Inc. hold?
Cipla USA Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Cipla USA Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors